Medical Research Council, UK
2017-2020, R Spiller, A Emmanuel, P Whorwell, M Scott, Phil Dinning, A Ford, A Farmer, et al. Project: Novel diagnostics and treatments for Irritable Bowel Syndrome, $3,716,909 AUD (£2,323,053.94).
2016-2018, R Spiller, L Marciani, P Gowland, G Major, G Moran, M Scott, C Knowles, C Hoad, S Taylor, A Emmanuel, C Coupland, Phil Dinning. Project: The causes of constipation. Reclassifying constipation using MRI and high resolution manometry to define mechanism of disease and target treatment, $2,520,826 AUD (£1,244,902).
Novo Nordisk Foundation
2017, F Knop, P Rossing, D Keating, J Jelsing, J Holst. Project: Anatomical and physiological delineation of gut-derived glucagon in man, $632,000.
Stiftelsen Olle Engqvist Byggmästare (admin through Uppsala University, Sweden)
2017-2018, Karin Nordstrom and Shannon Olsson (NCBS). Project: Multi-modal factors involved in hoverfly pollination: Behaviour and neural coding, $140,000 AUD.
2017, Briony Forbes' joint application with Adelaide University. Analysis of novel monotreme GLP-1 based receptor agonists
for use in metabolic disorder treatment, $200,000.
World Cancer Research Fund International
2016-2019, Janni Petersen. Project: Characterisation of TORC1 control of AMPK activity, $392,440.
Health Research Council, NZ
2016-2019, G O’Grady, I Bissett, L Cheng, P Du, N Paskaranandavadivel, C Stinear, Phil Dinning. Project: Mechanistic, Diagnostic and Therapeutic Advances in Fecal Incontinence and Anterior Resection Syndrome, $1,133,353 AUD ($1,200,000 NZ).